Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

NZ sharemarket rises ahead of interest rate decision
Markets Market close

NZ sharemarket rises ahead of interest rate decision

The S&P/NZX 50 Index closed at 12,765.24, up 28.18 points or 0.22%.

Graham Skellern 21 Nov 2024
IkeGPS revenue shows sparks for subscriptions play
Markets

IkeGPS revenue shows sparks for subscriptions play

Despite a $7m net loss, subscription revenue grew 28%.

Ben Moore 21 Nov 2024
My Food Bag profitability up, customer numbers dip
Retail

My Food Bag profitability up, customer numbers dip

Company expects market conditions to remain challenging in the second half.

Gregor Thompson 21 Nov 2024
Aft takes $6.5m hit on doctor strike and destocking
Markets

Aft takes $6.5m hit on doctor strike and destocking

Income in international markets affected by two events.